EBX-002

N/A

Report date: 2024/03/29 15:31:42

Base Information

Drug NameEBX-002
Drug Alias NameAmikacin+potentiator (Spexis)EBX-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsMycobacterium Infections, Nontuberculous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSpexis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSpexis Ltd
Inactive CompaniesN/A
Active IndicationsMycobacterium Infections, Nontuberculous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A